Agenda and minutes for the 98th ACAF meeting
Last updated: 10 July 2025
On this page
Skip the menu of subheadings on this page.Agenda
1. Apologies and announcements
2. Welcome – Members, Secretariat and Policy colleagues.
3. Risk Assessment update – Members will receive an update on the work being done by the FSA related to Regulated Products.
4. Policy update – Members will receive an update on the work being done by the FSA related to Regulated Products.
5. Minutes from the 97th ACAF meeting – Members will review the minutes from the last meeting and provide comments on any changes needed. ACAF/98/01.
6. Dossier for assessment: RP1605 Titanium dioxide - Members will discuss the paper and carry out a risk assessment of the additive. ACAF/98/02
7. Dossier for assessment: RP2105 Saccharomyces cerevisiae CNCM I-1079 – Members will discuss the application dossier and carry out a risk assessment of the efficacy section. ACAF/98/03.
8. Dossier for assessment: RP2163 – B-Act – Members will discuss the application dossier and carry out a risk assessment of the efficacy section. ACAF/98/04.
9. Dossier for assessment: RP2187 Pediococcus pentosaceus NCIMB 12674 – Members will discuss the application dossier and carry out a full risk assessment of the additive. ACAF/98/05.
10. Dossier for assessment: RP2252 Vitamin B12 (cyanocobalamin) – Members will discuss the application dossier and carry out a full risk assessment of the additive. ACAF/98/06.
11. Response to RFI: RP2071 Enterosure Conc – Members will revisit the applicant’s response to the Committee’s request. ACAF/98/07.
12. Response to RFI: RP2157 Bovacillus® 10 and Bovacillus® WS– Members will revisit the applicant’s response to the Committee’s request. ACAF/98/08.
13. Draft assessment – RP1696 – Members will evaluate the draft assessment and provide feedback on the content of the document. ACAF/98/09.
14. Any other business
Upcoming applications
Date of the next meeting: 24th July 2025 on Microsoft Teams.
Minutes
coming soon